Networks
Clinical Studies (3)
- Girometti : Study aims to describe the demographic and clinical characteristics of patients diagnosed with human mpox attending a sexual health centre in the UK
- A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥ 18 Years of Age to <50 Years of Age : Study aims to assess the safety, tolerability and immunogenicity of mRNA-1769 in healthy adult participants
- Agunbiade : Study aims to analyse the effectiveness of the MVA-BN vaccination in preventing mpox in individuals, particularly gay, bisexual, and other men who have sex with men and people living with HIV. To assess the clinical characteristics and patient management of those who developed mpox after receiving the vaccination
External Links
Other information
If you would like to contact the site, please email: ccb@ateneo.univr.it
The data is updated up to